| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
13.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
8,851 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$2,012,670 |
$2,012,670 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
11,609 |
11,681 |
63,744 |
167,262 |
| Total Sell Value |
$1,891,338 |
$1,906,248 |
$12,326,709 |
$40,328,387 |
| Total People Sold |
1 |
2 |
4 |
7 |
| Total Sell Transactions |
1 |
2 |
8 |
20 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lemoine David A |
Director |
• • – |
2019-05-16 |
4 |
OE |
$26.00 |
$227,552 |
D/D |
8,752 |
17,900 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2019-05-15 |
4 |
S |
$104.78 |
$408,652 |
D/D |
(3,900) |
39,244 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2019-05-15 |
4 |
AS |
$102.49 |
$89,576 |
D/D |
(874) |
9,148 |
|
- |
|
| Colleran David |
SVP, Secretary and GC |
• • – |
2019-04-02 |
4 |
AS |
$94.89 |
$701,712 |
D/D |
(7,395) |
30,433 |
|
- |
|
| Colleran David |
SVP, Secretary and GC |
• • – |
2019-04-02 |
4 |
OE |
$30.98 |
$229,097 |
D/D |
7,395 |
37,828 |
|
- |
|
| Kapples John W. |
SVP, Secretary and GC |
• • – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,825 |
9,825 |
|
- |
|
| Abdel-Malek Aiman |
EVP & Chief Technology Officer |
• • – |
2019-03-28 |
4 |
D |
$94.04 |
$404,842 |
D/D |
(4,305) |
19,687 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-20 |
4 |
AS |
$100.00 |
$500,000 |
D/D |
(5,000) |
11,743 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-20 |
4 |
OE |
$21.35 |
$106,750 |
D/D |
5,000 |
16,743 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-12 |
4 |
AS |
$95.00 |
$475,000 |
D/D |
(5,000) |
11,743 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-12 |
4 |
OE |
$21.35 |
$106,750 |
D/D |
5,000 |
16,743 |
|
- |
|
| Abdel-Malek Aiman |
EVP & Chief Technology Officer |
• • – |
2019-03-12 |
4 |
S |
$94.03 |
$2,571,613 |
D/D |
(27,349) |
23,992 |
|
- |
|
| Abdel-Malek Aiman |
EVP & Chief Technology Officer |
• • – |
2019-03-12 |
4 |
OE |
$31.20 |
$1,014,381 |
D/D |
27,349 |
51,341 |
|
- |
|
| Petrovic Shacey |
President and CEO |
• • – |
2019-03-06 |
4 |
AS |
$92.64 |
$98,754 |
D/D |
(1,066) |
96,454 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-06 |
4 |
AS |
$92.64 |
$926,400 |
D/D |
(10,000) |
11,743 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2019-03-06 |
4 |
OE |
$21.35 |
$213,500 |
D/D |
10,000 |
21,743 |
|
- |
|
| Colleran David |
SVP, Secretary and GC |
• • – |
2019-03-01 |
4 |
S |
$94.65 |
$1,985,359 |
D/D |
(20,975) |
30,433 |
|
- |
|
| Colleran David |
SVP, Secretary and GC |
• • – |
2019-03-01 |
4 |
OE |
$29.26 |
$745,544 |
D/D |
20,975 |
51,408 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2019-03-01 |
4 |
S |
$94.29 |
$52,896 |
D/D |
(561) |
10,022 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFO |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,198 |
24,727 |
|
- |
|
| Abdel-Malek Aiman |
EVP & Chief Technology Officer |
• • – |
2019-03-01 |
4 |
S |
$95.22 |
$153,119 |
D/D |
(1,608) |
23,992 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFOOfficer |
• – – |
2019-02-27 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,529 |
|
- |
|
| Levitz Michael L |
SVP and CFO |
• • – |
2019-02-27 |
4 |
AS |
$92.01 |
$124,214 |
D/D |
(1,350) |
56,651 |
|
- |
|
| Benjamin Eric |
SVP, R&D, New Prod Dev. & Comm |
• • – |
2019-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,154 |
12,177 |
|
- |
|
| Benjamin Eric |
SVP, R&D, New Prod Dev. & Comm |
• • – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,308 |
13,331 |
|
- |
|
1123 Records found
|
|
Page 16 of 45 |
|
|
3.15 (1.85%) 
